Vandebroek named CFO at Hyloris

Hyloris Pharmaceuticals S.A. (Euronext:HYL) hired Jean-Luc Vandebroek as CFO. Vandebroek was most recently CFO at Bone Therapeutics S.A. (Euronext:BOTHE), where he will remain a non-executive director. Lieve Creten, a 15-year veteran of Deloitte Financial Advisory Belgium, became the interim-CFO at Bone Therapeutics.

Cytokine and cell therapy company Brooklyn ImmunoTherapeutics LLC (NYSE:BTX) hired Roger Sidhu as CMO. Sidhu was VP of clinical development at Kite Pharma, and CMO and EVP and head of R&D at Roivant Sciences Ltd...